317 related articles for article (PubMed ID: 24746164)
1. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.
Hochberg FH; Atai NA; Gonda D; Hughes MS; Mawejje B; Balaj L; Carter RS
Expert Rev Mol Diagn; 2014 May; 14(4):439-52. PubMed ID: 24746164
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles as a Platform for Glioma Therapeutic Development.
Santiago-Dieppa DR; Gonda DD; Cheung VJ; Steinberg JA; Carter BS; Chen CC
Prog Neurol Surg; 2018; 32():172-179. PubMed ID: 29990983
[TBL] [Abstract][Full Text] [Related]
4. ExRNA in Biofluids as Biomarkers for Brain Tumors.
Rennert RC; Hochberg FH; Carter BS
Cell Mol Neurobiol; 2016 Apr; 36(3):353-60. PubMed ID: 26993514
[TBL] [Abstract][Full Text] [Related]
5. [Biomarkers of glioma: recent advance and potential applications].
Yu SZ; Wang Q
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
[No Abstract] [Full Text] [Related]
6. Biomarkers usher in era of personalized care for malignant glioma patients.
Chakravarti A; Palanichamy K; Bell EH
CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
[No Abstract] [Full Text] [Related]
7. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
[TBL] [Abstract][Full Text] [Related]
8. Neuro-oncology: Implications of the molecular era.
Ruff MW; Uhm JH; Benarroch EE
Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of extracellular vesicles as non-invasive biomarkers in glioma diagnosis, prognosis, and treatment response monitoring.
Sourani A; Saghaei S; Sabouri M; Soleimani M; Dehghani L
Mol Biol Rep; 2021 Oct; 48(10):6971-6985. PubMed ID: 34460059
[TBL] [Abstract][Full Text] [Related]
10. FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular Vesicles.
Ricklefs FL; Maire CL; Matschke J; Dührsen L; Sauvigny T; Holz M; Kolbe K; Peine S; Herold-Mende C; Carter B; Chiocca EA; Lawler SE; Westphal M; Lamszus K
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178271
[TBL] [Abstract][Full Text] [Related]
11. [Extracellular vesicles for diagnosis and therapy of gliomas: problems and opportunities].
Filin AA; Chernysheva AA; Pavlova GV; Loshhenov VB; Gurina OI
Biomed Khim; 2022 Dec; 68(6):419-426. PubMed ID: 36573408
[TBL] [Abstract][Full Text] [Related]
12. Glioma-derived extracellular vesicles promote tumor progression by conveying WT1.
Tsutsui T; Kawahara H; Kimura R; Dong Y; Jiapaer S; Sabit H; Zhang J; Yoshida T; Nakada M; Hanayama R
Carcinogenesis; 2020 Sep; 41(9):1238-1245. PubMed ID: 32463428
[TBL] [Abstract][Full Text] [Related]
13. Circulating biomarkers for high-grade glioma.
Loo HK; Mathen P; Lee J; Camphausen K
Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
[No Abstract] [Full Text] [Related]
14. Clinical practice guidelines for the management of adult diffuse gliomas.
Jiang T; Nam DH; Ram Z; Poon WS; Wang J; Boldbaatar D; Mao Y; Ma W; Mao Q; You Y; Jiang C; Yang X; Kang C; Qiu X; Li W; Li S; Chen L; Li X; Liu Z; Wang W; Bai H; Yao Y; Li S; Wu A; Sai K; Li G; Yao K; Wei X; Liu X; Zhang Z; Dai Y; Lv S; Wang L; Lin Z; Dong J; Xu G; Ma X; Zhang W; Zhang C; Chen B; You G; Wang Y; Wang Y; Bao Z; Yang P; Fan X; Liu X; Zhao Z; Wang Z; Li Y; Wang Z; Li G; Fang S; Li L; Liu Y; Liu S; Shan X; Liu Y; Chai R; Hu H; Chen J; Yan W; Cai J; Wang H; Chen L; Yang Y; Wang Y; Han L; Wang Q; ; ; ; ;
Cancer Lett; 2021 Feb; 499():60-72. PubMed ID: 33166616
[TBL] [Abstract][Full Text] [Related]
15. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.
Weller M; van den Bent M; Hopkins K; Tonn JC; Stupp R; Falini A; Cohen-Jonathan-Moyal E; Frappaz D; Henriksson R; Balana C; Chinot O; Ram Z; Reifenberger G; Soffietti R; Wick W;
Lancet Oncol; 2014 Aug; 15(9):e395-403. PubMed ID: 25079102
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis.
Wang L; Yu Z; Sun S; Peng J; Xiao R; Chen S; Zuo X; Cheng Q; Xia Y
Rev Neurosci; 2017 May; 28(4):375-380. PubMed ID: 28107175
[TBL] [Abstract][Full Text] [Related]
18. Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics.
Hench J; Bihl M; Bratic Hench I; Hoffmann P; Tolnay M; Bösch Al Jadooa N; Mariani L; Capper D; Frank S
Neuro Oncol; 2018 Nov; 20(12):1682-1683. PubMed ID: 30169880
[No Abstract] [Full Text] [Related]
19. Progress in the study of markers related to glioma prognosis.
Luo Y; Hou WT; Zeng L; Li ZP; Ge W; Yi C; Kang JP; Li WM; Wang F; Wu DB; Wang RY; Qu BL; Li XF; Wang JJ
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7690-7697. PubMed ID: 32744695
[TBL] [Abstract][Full Text] [Related]
20. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
